Department of Urology, Roswell Park Cancer Institute, Buffalo, NY.
Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, NY.
Urology. 2014 Feb;83(2):350-6. doi: 10.1016/j.urology.2013.09.056.
To characterize the outcomes and predictors of readmission after robot-assisted radical cystectomy (RARC) during early (30-day) and late (31-90-day) postoperative periods.
We retrospectively evaluated our prospectively maintained RARC quality assurance database of 272 consecutive patients operated between 2005 and 2012. We evaluated the relationship of readmission with perioperative outcomes and examined possible predictors during the postoperative period.
Overall 30- and 90-day mortality was 0.7% and 4.8%, respectively, with 25.5% patients readmitted within 90 days after RARC (61% of them were readmitted within 30 days and 39% were readmitted between 31-90 days postoperatively). Infection-related problems were the most common cause of readmission during early and late periods. Overall operative time and obesity were significantly associated with readmission (P = .034 and .033, respectively). Body mass index and female gender were independent predictors of 90-day readmission (P = .004 and .014, respectively). Having any type of complication correlated with 90-day readmission (P = .0045); meanwhile, when complications were graded on the basis of Clavien grading system, only grade 1-2 complications statistically correlated with readmission (P = .046). Four patients needed reoperation (2 patients in early "for appendicitis and adhesive small bowel obstruction" and 2 in late "for ureteroenteric stricture" readmission); meanwhile, 6 patients needed percutaneous procedures (4 patients in early "1 for anastomotic leak and 3 for pelvic collections" and 2 "for pelvic collections and ureterocutaneous fistula" in late readmission).
The rate of readmission within 90 days after RARC is significant. Female gender and body mass index are independent predictors of readmission. Outcomes at 90 days provide more thorough results, essential to proper patient counseling.
描述机器人辅助根治性膀胱切除术(RARC)后早期(30 天)和晚期(31-90 天)术后再入院的结局和预测因素。
我们回顾性评估了我们前瞻性维护的 2005 年至 2012 年间连续 272 例接受 RARC 治疗的患者的 RARC 质量保证数据库。我们评估了再入院与围手术期结果的关系,并在术后期间检查了可能的预测因素。
总体 30 天和 90 天死亡率分别为 0.7%和 4.8%,25.5%的患者在 RARC 后 90 天内再入院(其中 61%在 30 天内再入院,39%在 31-90 天内再入院)。感染相关问题是早期和晚期再入院的最常见原因。总手术时间和肥胖与再入院显著相关(P =.034 和.033)。体重指数和女性是 90 天再入院的独立预测因素(P =.004 和.014)。任何类型的并发症与 90 天再入院相关(P =.0045);同时,当并发症根据 Clavien 分级系统进行分级时,只有 1-2 级并发症与再入院有统计学相关性(P =.046)。4 名患者需要再次手术(2 名在早期因“阑尾炎和粘连性小肠梗阻”,2 名在晚期因“输尿管肠吻合口狭窄”);同时,6 名患者需要进行经皮手术(4 名在早期因“吻合口漏和 3 名因盆腔积液”,2 名在晚期因“盆腔积液和输尿管皮肤瘘”)。
RARC 后 90 天内再入院率较高。女性和体重指数是再入院的独立预测因素。90 天的结果提供了更全面的结果,对于适当的患者咨询至关重要。